Neurologists, try using your brains first! Horowitz'1 enthusiastic advocacy of aggressive competition with less well-trained physicians for the tissue-type plasminogen activator treatment market should not, I hope, lead us toward the tactics of used car salesmen. I agree that treatment with tissue-type plasminogen activator should be offered to the patient with fresh stroke whose computed tomographic scan shows no blood. But I believe that an ethical explanation to him/her and his/her family (not a sales pitch) should indicate the following:
Landau WM. Thrombolytic Therapy in Acute Stroke. Arch Neurol. 1998;55(10):1378. doi:
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: